Payden & Rygel
- SEC CIK
- 0000919219
- Latest filing
- Jul 31, 2026
TMO holding history
Thermo Fisher Scientific Inc. in every 13F filed by Payden & Rygel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TMO overviewAll 13F holders of TMOFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −16,400−100.0% | Sold out | Holders |
| Q1 2026 | 16,400 | $8.06M | 0.6% | +16,400 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −1,800−100.0% | Sold out | Holders |
| Q3 2024 | 1,800 | $1.11M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,800 | $995.0K | 0.1% | −1,100−37.9% | Reduced | Holders |
| Q1 2024 | 2,900 | $1.69M | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,900 | $1.54M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2,900 | $1.47M | 0.1% | −600−17.1% | Reduced | Holders |
| Q2 2023 | 3,500 | $1.83M | 0.1% | −2,000−36.4% | Reduced | Holders |
| Q1 2023 | 5,500 | $3.17M | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2022 | 5,500 | $3.03M | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2022 | 5,500 | $2.79M | 0.2% | +2,000+57.1% | Added | Holders |
| Q2 2022 | 3,500 | $1.90M | 0.1% | +3,500 | New | Holders |